Pharmacielo Ltd. · TSXV:PCLO
Pharmacielo — Investor Presentation (November 2018)
23 slides from Pharmacielo's investor presentation, November 2018
Slide 1: Investor Presentation
Investor Presentation November 2018
Slide 2: Disclaimer and Cautionary Note Regarding Forward-Looking Statements
Disclaimer and Cautionary Note Regarding Forward- Looking Statements This presentation (“Presentation”) is confidential and contains proprietary non-public information regarding PharmaCielo Ltd. (the “Company”, “we”, “us” or “our”) which is an Ontario-based private company. Under no circumstances ma
Slide 3: Typical North American Producer
Typical North American Producer Artificial Climate Control System High Intensity Lighting System Municipal Water Supply 2
Slide 4: It's The Natural Choice
It’s The Natural Choice Natural Sunlight Spring Fed Water Fully Licensed 3 3
Slide 5: The Natural Cannabis Belt
The Natural Cannabis Belt Only a few places globally where you can efficiently grow cannabis Even fewer with the infrastructure & political climate to support it Tropic of Cancer Venezuela Guyana Suriname Equator Colombia French Guiana Ecuador Brazil Peru Tropic of Capricorn Natural & consistent 12-
Slide 6: Colombia
Colombia Ideal Growing Environment 2nd largest supplier of Cut Flowers Medellín Stable Government 3rd largest supplier of Coffee Low Energy Costs Scalable Cultivation Infrastructure 5th largest supplier of Bananas Experienced Human Capital & Significant, Scalable Cultivation Infrastructure 5
Slide 7: Natural Cost Advantage
Natural Cost Advantage Licensed Producer Aspiration VS Per Gram Per Gram 6
Slide 8: Experienced Management Team
Experienced Management Team Anthony Wile, CEO, Director Marcelo Antunes De Siqueira, COO (Nursery & Propagation A co-founder of PharmaCielo and involved in its operations since the company was Centre) established. An entrepreneur, business strategist, publisher and author, Mr. Wile A horticultural e
Slide 9: Non-Executive Board Members
Non-Executive Board Members Simon Langelier, Chairman of the Board ● Dr. Delon Human, Vice Chairman ● ● Henning von Koss, Director ● Matteo Pellegrini, Director David Attard, Director ● ● Carlos Manuel Uribe, Director ● David Gordon, Director ● 8
Slide 10: Licensed by the Colombian Government
Licensed by the Colombian Government Step 1: Processing and Extraction Licence ▪ Received June 27th, 2016 Step 2: Cultivation Licence ▪ Received October 19th, 2017 The only fully licensed producer Step 3: of medicinal cannabis oil products Exportation Permit in Colombia for use in Colombia as well a
Slide 11: Company Owned and Contract Cultivation Facilities
Company Owned and Contract Cultivation Facilities Nursery & Propagation Centre 1.3 Million sq. ft. open-air greenhouses 480 Thousand KG flower capacity per year Company-Owned with Indigenous Growers 0.4 Million sq. ft. open-air greenhouses 150 Thousand KG flower capacity per year Contract Growers 13
Slide 12: Highly Scalable Business Model
Highly Scalable Business Model Nursery & Propagation Centre Oil Processing Centre Supplies cuttings to support Supplies harvested cannabis 100+ million sq. ft. of cultivation flower to be processed Contract and Indigenous Growing 11
Slide 13: Our Current Capacity vs Fully Funded Canadian Projections
Our Current Capacity vs Fully Funded Canadian Projections 6,000 Set to meet the Indigenous Growers global medicinal 5,000 Nursery & Propagation need for high-quality 4,000 cannabis oil THOUSANDS OF KGS Combined Canadian LPs Contract 2020 Supply 3,000 Growing 2,000 1,000 Owned Owned 0 Source: Company
Slide 14: Our Nursery and Propagation Centre
Our Nursery and Propagation Centre 13
Slide 15: GMP Oil Processing Centre
— PharmaCielo Nature's Coie From Colombia
Slide 16: Distribution Channel Strategy
Distribution Channel Strategy Direct Distribution Retail Distribution Finished Goods Manufacturing Research & Scientific Partners 15
Slide 17: Colombia: First Mover Advantage
Colombia: First Mover Advantage Barranquilla Population of 48.7 Million Cartagena Cúcuta Medicinal Cannabis Legalized December 2015 Medellín Bucaramanga Estimated Cannabis Market Size of ~ $2 Billion* Bogota Estimated PharmaCielo Market Share ~ 30% Cali Estimated Potential Revenue ~ $600 Million Pas
Slide 18: Colombia: Go to Market Strategy
Colombia: Go to Market Strategy • UBIQUO: Colombia’s only patient & e-clinic platform (80,000 patients) • Fully owned by PharmaCielo • Currently only in Medellín • Expected to grow 350,000+ patients over a 36-month period as we roll out to seven new departments (regions) • Company-owned-and-operated
Slide 19: Colombia Can Supply The World
Colombia Can Supply The World Population: 508.0 M Global Opportunity Potential Population: 127.5 M ● ~$200B Industry Primary Focus Population: by 2032* Secondary Focus 207.7 M *(based on Constellation Brands market estimate) 18
Slide 20: Investment Highlights
Investment Highlights • Efficient, Natural Production • Fully Licensed & Operational • Scalable Cultivation Facilities • Advanced Processing Facilities • Strong Management Team 19
Slide 21: 20
20
Slide 22: Environmental Impact
Environmental Impact Environmental Impact The equator is the only place to grow without damaging the environment Global Square Meters Requirement / kg1 3,700 The full study can be found at: The Huge (or Tiny) Ecological Footprint of 10 80 Cannabis https://www.footprintnetwork.org/2017/0 PharmaCielo
Slide 23: Licensed by the Colombian Government
Licensed by the Colombian Government Licence Overview Processing and Extraction of Cannabis Oil Extracts Licence ▪ Legalized in December 2015 by signing of Decree 2467 by President Santos ▪ Colombia granted PharmaCielo the first Processing and Extraction License on June 27, 2016. o July 2016 – Congr